The National Drug Scheduling Advisory Committee (NDSAC) reviews and analyzes submissions from sponsors requesting scheduling placements and also conducts independent research of the issues as needed.
The Committee was established to advise the provincial pharmacy regulatory authorities on matters relating to the placement of drugs within a three schedule/four category national model, through:
- application of the drug scheduling factors and the cascading principle in making schedule recommendations. Determination of the appropriate schedule for a drug is made using the factors to find the best “fit”.
- recommendations on the appropriate conditions and place of sale of drugs in Canada, and
- evaluation and maintenance of the drug scheduling factors.
Meeting quorum is five voting members with voting by simple majority. Members must attend at least three out of four meetings per calendar year and not be absent for two consecutive meetings.